At ESMO Congress 2019, one of the Patient Advocacy sessions addressed a key issue in the management of non-small cell lung cancer, i.e. having a common cancer split into different subgroups. With more molecular target being identified, some new challenges have emerged as highlights Dr Enriqueta Felip, from Vall d'Hebron University Hospital, Barcelona, Spain.
NSCLC: challenges of a common cancer split into subgroups
